We are live on
!
Find out more
UOC
UBS O'Connor Portfolio holdings
AUM
$3.38B
1-Year Est. Return
63.08%
This Fund
S&P 500
This Quarter
Est. Return
+7.76%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.75B
AUM Growth
+$529M
(+13%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-2.91%
Top 10 Holdings %
Top 10 Hldgs %
47.97%
Holding
745
New
128
Increased
150
Reduced
259
Closed
162
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$253M |
| 2 |
PDCE
PDC Energy, Inc.
PDCE
|
+$210M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$206M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$135M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$87.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Horizon
FHN
|
+$179M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$146M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$70.5M |
| 4 |
Tower Semiconductor
TSEM
|
+$50.8M |
| 5 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$45.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.35% |
| 2 | Technology | 15.53% |
| 3 | Financials | 11.99% |
| 4 | Real Estate | 8.48% |
| 5 | Materials | 5.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSN
601
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-18,508
| Closed | -$2.71M |
|
602
MultiSensor AI
MSAI
$10.7M
| – | – |
-5,908
| Closed | -$2.46M |
|
|
MTAL
603
DELISTED
Metals Acquisition
MTAL
| – | – |
-227,558
| Closed | -$2.33M |
|
604
Meritage Homes
MTH
$4.86B
| – | – |
-47,006
| Closed | -$2.74M |
|
605
Netflix
NFLX
$309B
| – | – |
-10,330
| Closed | -$357K |
|
606
NET Power
NPWR
$134M
| – | – |
-472,621
| Closed | -$4.84M |
|
607
NetApp
NTAP
$37.1B
| – | – |
-25,000
| Closed | -$1.6M |
|
608
CALL
Opendoor
OPEN
$3.46B
| – | – |
-103,333
| Closed | -$22.5K |
|
609
Palo Alto Networks
PANW
$298B
| – | – |
-66,760
| Closed | -$6.67M |
|
610
Vaxcyte
PCVX
$8.79B
| – | – |
-8,071
| Closed | -$303K |
|
611
PennyMac Financial
PFSI
$4.02B
| – | – |
-4,035
| Closed | -$256K |
|
612
Pliant Therapeutics
PLRX
$64.4M
| – | – |
-10,500
| Closed | -$279K |
|
613
ProKidney
PROK
$345M
| – | – |
-49,782
| Closed | -$564K |
|
614
PTC
PTC
$16.2B
| – | – |
-4,000
| Closed | -$513K |
|
615
Replimune Group
REPL
$1.02B
| – | – |
-39,500
| Closed | -$698K |
|
616
Rivian
RIVN
$22.8B
| – | – |
-34,000
| Closed | -$526K |
|
617
Rhythm Pharmaceuticals
RYTM
$7.96B
| – | – |
-56,050
| Closed | -$1,000K |
|
618
SAP
SAP
$239B
| – | – |
-1,937
| Closed | -$245K |
|
619
S&P Global
SPGI
$121B
| – | – |
-9,000
| Closed | -$3.1M |
|
620
ARS Pharmaceuticals
SPRY
$598M
| – | – |
-149,915
| Closed | -$976K |
|
621
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$822B
| – | – |
-440,000
| Closed | -$936K |
|
622
STAG Industrial
STAG
$7.1B
| – | – |
-189,389
| Closed | -$6.41M |
|
623
Stryker
SYK
$130B
| – | – |
-1,283
| Closed | -$366K |
|
|
TGI
624
PUT
DELISTED
Triumph Group
TGI
| – | – |
-30,600
| Closed | -$43.6K |
|
625
Uber
UBER
$153B
| – | – |
-29,830
| Closed | -$946K |
|
Similar funds
FNBT
SAG
ACI
TCOV
RC
A
CGL
CB
UBS O'Connor's Q2 2023 Portfolio in Review
As of Q2 2023, UBS O'Connor held 745 positions worth $4.75B, up 13% from $4.22B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
UBS O'Connor's Q2 2023 filing shows 128 new, 150 increased, 259 reduced and 162 closed positions. Its largest new stake was PDC Energy, Inc.: 3,101,445 shares worth $221M. The largest sale was First Horizon, an estimated $179M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 21% a quarter earlier, followed by Technology and Financials.
- UBS O'Connor's largest Q2 2023 buy was PDC Energy, Inc.: 3,101,445 shares worth $221M.
- UBS O'Connor added most to Seagen Inc. Common Stock in Q2 2023, an estimated $253M increase.
- UBS O'Connor's biggest Q2 2023 reduction was Tower Semiconductor, cutting an estimated $50.8M.
- UBS O'Connor fully exited First Horizon in Q2 2023, selling an estimated $179M.
- UBS O'Connor's ten largest holdings make up 48% of its $4.75B portfolio in Q2 2023.
- UBS O'Connor opened 128 new positions and closed 162 in Q2 2023.
- UBS O'Connor's portfolio value rose 13% quarter-over-quarter to $4.75B.
Based on UBS O'Connor's 13F filing for Q2 2023, filed 14 Aug 2023.